rethinkTHC Search
Menu
Study breakdown

A Clinical Guide for Evaluating Cannabis Product Quality and Safety

evidence
The takeaway

A clinical framework was developed to help clinicians evaluate the quality and safety of cannabis products patients bring to clinical encounters.

Primary care providers, pharmacists, medical cannabis clinicians, and patients wanting to evaluate product quality.

Quality framework

Structured clinical criteria developed for assessing cannabis product quality and safety

What the researchers found

The framework provides clinicians with structured criteria for assessing cannabis product quality, including regulatory status, testing documentation, labeling accuracy, and contaminant screening, enabling informed clinical conversations.

Why it matters

As medical cannabis use grows, clinicians need practical tools to evaluate the wide range of products patients use, many of which vary dramatically in quality and may not match label claims.

The numbers in context

The framework addresses the increase in medical cannabis use and the variety of available products that clinicians may encounter in practice.

How the study worked

Clinical framework development for cannabis product quality and safety evaluation.

Who was studied

Clinicians evaluating cannabis products presented by patients in clinical practice.

What this study cannot tell us

Framework applicability varies by jurisdiction and regulatory environment; rapid market changes may outpace framework updates; not all product quality issues are visible to clinicians.

How to read the evidence

Expert-developed clinical framework; provides practical guidance but not empirical validation of outcomes.

When this study was published

Recent framework addressing a growing clinical need.

The bigger picture

This framework addresses a practical gap in medical education where most clinicians receive no training in evaluating cannabis products, despite increasing patient use and questions.

Replication

Practical clinical tool; validation through clinical implementation and outcomes assessment needed.

Funding

Not specified

Conflicts of interest

Not specified

Questions still open

  • Should clinicians be required to know about cannabis product quality?
  • How can patients verify product quality independently?
  • What role should dispensaries play in product quality education?

Read the original research

A Clinical Framework for Evaluating Cannabis Product Quality and Safety.

Cannabis and cannabinoid research, 8(3), 567-574

Citation

MacCallum, Caroline A; Lo, Lindsay A; Pistawka, Carly A; Boivin, Michael. (2023). A Clinical Framework for Evaluating Cannabis Product Quality and Safety.. Cannabis and cannabinoid research, 8(3), 567-574. https://doi.org/10.1089/can.2021.0137